Olaparib maintenance versus placebo or standard of care in ovarian cancer: a biomarker-driven systematic review and meta-analysis of randomized trials
Farida NamozovaTashkent Medical Academy, Tashkent, Uzbekistan. [email protected]Isadora Mamede Mendes da SilvaFederal University of São João del-Re, Divinópolis, BrazilCarolina Alves FelippeUniversity of Grande Rio "José de Souza Herdy" (UNIGRANRIO), Rio de Janeiro, BrazilEllen RodriguesDepartment of Obstetrics and Gynecology, São Paulo Municipal Health, São Paulo, BrazilCarlos SteccaDivision of Medical Oncology, BC Cancer, Abbotsford, Canada
2026en
Ochiq kirish: yoʻq
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos26 ta foydalanilgan manba